{"id":"https://openalex.org/A5146671995","orcid":null,"observed_orcids":[],"display_name":"Malina Doynova","raw_author_names":["Malina Doynova"],"full_name":"Malina Doynova","works_count":2,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5146671995","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I132053463","ror":"https://ror.org/01r9htc13","display_name":"Universit\u00e9 Libre de Bruxelles","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I2801838318","ror":"https://ror.org/05e8s8534","display_name":"Institut Jules Bordet","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I132053463","ror":"https://ror.org/01r9htc13","display_name":"Universit\u00e9 Libre de Bruxelles","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","ror":"https://ror.org/05e8s8534","display_name":"Institut Jules Bordet","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"topics":[{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","count":1,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11482","display_name":"RNA modifications and cancer","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":1.79e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","value":1.27e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11482","display_name":"RNA modifications and cancer","value":1.22e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","value":1.18e-05,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","value":6.6e-06,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","score":0.6165000200271606},{"id":"127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","score":0.3215000033378601},{"id":"127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","score":0.30390000343322754},{"id":"117838200","wikidata":"https://www.wikidata.org/wiki/Q14592582","display_name":"Stress granule","score":0.26980000734329224},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.2574999928474426}],"counts_by_year":[{"year":2026,"works_count":2,"oa_works_count":1,"cited_by_count":0}],"display_name_alternatives":["Malina Doynova"],"block_key":"m doynova","works_api_url":"https://api.openalex.org/works?filter=author.id:A5146671995","updated_date":"2026-10-10T12:59:14","created_date":"2026-05-19T00:00:00"}